ES2038166T3 - Procedimiento para preparar un derivado de indenotiazol. - Google Patents

Procedimiento para preparar un derivado de indenotiazol.

Info

Publication number
ES2038166T3
ES2038166T3 ES198787200041T ES87200041T ES2038166T3 ES 2038166 T3 ES2038166 T3 ES 2038166T3 ES 198787200041 T ES198787200041 T ES 198787200041T ES 87200041 T ES87200041 T ES 87200041T ES 2038166 T3 ES2038166 T3 ES 2038166T3
Authority
ES
Spain
Prior art keywords
group
hydrogen atom
low alkyl
unsubstituted
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787200041T
Other languages
English (en)
Inventor
Masayoshi Tsuji
Akira Nakagawa
Hisataka Inoue
Terumi Hachiya
Yoshihiro Tanoue
Kouichi Ikesue
Masaru Saita
Takenobu Misoguchi
Tetuo Aoki
Hironobu Satoh
Kanji Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2038166T3 publication Critical patent/ES2038166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVENCION SE REFIERE A UN NUEVO DERIVADO DE INDENOTIAZOL, REPRESENTADO POR LA FORMULA (IA) EN LA QUE X E Y SON IGUALES O DIFERENTES Y PUEDEN SER UN ATOMO DE H O DE HALOGENO, UN ALQUILO O ALCOXI DE CADENA CORTA; N ES UN ENTERO ENTRE 0 Y 4; R1 ES H, UN ALQUILO DE CADENA CORTA O UN GRUPO FENILO QUE PUEDE ESTAR SUSTITUIDO; R2 ES UN GRUPO ALQUILO O ALCOXI DE CADENA CORTA, CICLOALQUILO, FENOXI O FENILO QUE PUEDEN ESTAR SUSTITUIDOS, ALQUENILO, HETEROCICLICO O CICLOAMINO; R3 ES H, UN GRUPO ALQUILO SUSTITUIDO DE CADENA CORTA O ACIDO, Y R2 Y R3 PUEDEN RECOMBINARSE PARA FORMAR UN GRUPO CICLOAMINO. TAMBIEN SE REFIERE LA INVENCION A UN TAUTOMERO DEL COMPUESTO DE FORMULA IA EN LA QUE TODOS LOS SIMBOLOS SON LOS INDICADOS, EXCEPTO R3 QUE SE LIMITA A UN ATOMO DE H.
ES198787200041T 1986-01-16 1987-01-14 Procedimiento para preparar un derivado de indenotiazol. Expired - Lifetime ES2038166T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP764086 1986-01-16

Publications (1)

Publication Number Publication Date
ES2038166T3 true ES2038166T3 (es) 1993-07-16

Family

ID=11671425

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787200041T Expired - Lifetime ES2038166T3 (es) 1986-01-16 1987-01-14 Procedimiento para preparar un derivado de indenotiazol.

Country Status (12)

Country Link
US (1) US4877876A (es)
EP (1) EP0230334B1 (es)
JP (1) JPH0667919B2 (es)
KR (1) KR900003368B1 (es)
CN (1) CN87100171A (es)
AT (1) ATE75737T1 (es)
AU (1) AU598229B2 (es)
CA (1) CA1292226C (es)
DE (1) DE3778714D1 (es)
ES (1) ES2038166T3 (es)
SU (1) SU1609449A3 (es)
WO (1) WO1987004434A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69132006T2 (de) * 1990-11-30 2000-08-03 Otsuka Pharmaceutical Co., Ltd. Thiazolederivate als inhibitoren von aktivem sauerstoff
EP0749966A4 (en) * 1994-03-11 1997-07-02 Yamanouchi Pharma Co Ltd 5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT
TW416953B (en) 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE60006954T2 (de) 1999-05-10 2004-10-21 Warner Lambert Co Aromatische amide
RU2252219C2 (ru) * 1999-11-05 2005-05-20 Авентис Фарма Дойчланд Гмбх Производные индено-, нафто- и бензоциклогептадигидротиазола, их получение и их применение в качестве анорексических лекарственных средств
NZ520926A (en) * 2000-02-23 2004-08-27 Aventis Pharma Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SK285571B6 (sk) * 2000-02-26 2007-04-05 Sanofi-Aventis Deutschland Gmbh 8,8a-Dihydroindeno[1,2-d]tiazolové deriváty nesúce v polohe 2 substituent so sulfónamidovou štruktúrou, spôsob ich prípravy a farmaceutické prostriedky, ktoré ich obsahujú
AU2001280946A1 (en) * 2000-08-01 2002-02-13 University Of Virginia Patent Foundation Use of selective adenosine a1 receptor agonists, antagonists and allosteric enhancers to manipulate angiogenesis
US7485655B2 (en) * 2002-01-16 2009-02-03 University Of Virginia Patent Foundation 2-Aminothiazole allosteric enhancers of A1 adenosine receptors
AU2005268899B2 (en) * 2004-08-05 2009-09-24 F. Hoffmann-La Roche Ag Substituted N-acyl-2-aminothiazoles
TWI402261B (zh) * 2006-06-19 2013-07-21 Takeda Pharmaceutical 三環化合物及其醫藥組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082773A (en) * 1972-07-03 1978-04-04 E. R. Squibb & Sons, Inc. Tricyclic tetrahydro naphthaleneols and related compounds
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
DE3027528A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
CA1292226C (en) 1991-11-19
CN87100171A (zh) 1988-01-20
JPH0667919B2 (ja) 1994-08-31
SU1609449A3 (ru) 1990-11-23
JPS62252780A (ja) 1987-11-04
AU598229B2 (en) 1990-06-21
KR900003368B1 (ko) 1990-05-16
DE3778714D1 (de) 1992-06-11
AU6842087A (en) 1987-08-14
WO1987004434A1 (fr) 1987-07-30
EP0230334A1 (en) 1987-07-29
US4877876A (en) 1989-10-31
ATE75737T1 (de) 1992-05-15
EP0230334B1 (en) 1992-05-06
KR880700798A (ko) 1988-04-12

Similar Documents

Publication Publication Date Title
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
ES2038166T3 (es) Procedimiento para preparar un derivado de indenotiazol.
NO992549L (no) Sukkerforbindelse, geleringsmiddel og fremgangsmåte for fremstilling derav
DK164451C (da) 3-aminoquinolinderivat
KR830007487A (ko) 심장질환치료제의 제조방법
ES495249A0 (es) Procedimiento para la preparacion de difenileteres
DK0784055T3 (da) Pyrimidinylpyrazolderivater
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
YU91483A (en) Process for obtaining new thiomethylpyridine derivatives
DE3174132D1 (en) New ethenylimidazole derivatives, processes for their preparation and pharmaceutical compositions containing them; intermediates, useful in their preparation and a process for the preparation thereof
DE3363575D1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
ES8604912A1 (es) Procedimiento de preparacion de nuevos derivados de (arilpi-peraziniletilaminoetoxi)-4 fenol
MY100957A (en) Quinazolinone compounds and processes for the preparation thereof.
DE3469171D1 (de) Pesticidal benzoylurea derivatives
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments
MY103558A (en) Fungicides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 230334

Country of ref document: ES